Biotech · Private company · Warrington, PA, US
Windtree Therapeutics Inc
SEC CIK 0000946486
Track this companyFree. Adds Windtree Therapeutics Inc to your Dealase workspace and tells you when its record changes.
Clinical trials62 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- IstaroximePhase 2 · Cardiogenic ShockClinicalTrials.gov · fetched Nov 12, 2026
- LucinactantPhase 2 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- Lucinactant delivered via investigational delivery devicePhase 2 · Respiratory Distress SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Lucinactant for inhalationPhase 2 · Respiratory Distress SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- nCPAPPhase 2 · Respiratory Distress SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- nCPAP alonePhase 2 · Respiratory Distress SyndromeClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage CPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Jun 1, 2024ClinicalTrials.gov NCT05975021 · fetched Nov 12, 2026
- TH1902 in Patients With Advanced Solid TumorsPHASE1 · ACTIVE_NOT_RECRUITING · started Mar 4, 2021ClinicalTrials.gov NCT04706962 · fetched Nov 12, 2026
- The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19)PHASE2 · COMPLETED · started Jan 5, 2021ClinicalTrials.gov NCT04389671 · fetched Nov 12, 2026
- The Safety and Efficacy of Istaroxime for Pre-Cardiogenic ShockPHASE2 · COMPLETED · started Sep 28, 2020ClinicalTrials.gov NCT04325035 · fetched Nov 12, 2026
- The Safety and Efficacy of Lucinactant for Inhalation in Premature Neonates 26 to 32 Weeks Gestational AgePHASE2 · COMPLETED · started Dec 1, 2015ClinicalTrials.gov NCT02636868 · fetched Nov 12, 2026
- Trial To Assess The Safety And Tolerability Of Lucinactant For Inhalation In Preterm Neonates 26 to 28 Weeks PMAPHASE2 · TERMINATED · started Aug 1, 2015ClinicalTrials.gov NCT02528318 · fetched Nov 12, 2026
SEC filings12
- 8-K · FORM 8-KSEC EDGAR · filed Jul 22, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jan 7, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Dec 2, 2025 · fetched Nov 12, 2026
- 10-Q · FORM 10-QSEC EDGAR · filed Nov 19, 2025 · fetched Nov 12, 2026
- S-1 · FORM S-1SEC EDGAR · filed Oct 24, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Oct 16, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Oct 6, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Sep 8, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Sep 2, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Aug 20, 2025 · fetched Nov 12, 2026
- 10-Q · FORM 10-QSEC EDGAR · filed Aug 19, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Aug 8, 2025 · fetched Nov 12, 2026